Form 4: Guardant Health CIO Kalia Reports Routine Stock Transactions

Guardant Health's Chief Information Officer, Kumud Kalia, reported the acquisition of common stock through RSU vesting and the subsequent disposition of shares for tax purposes.

Summary

• Kumud Kalia, Chief Information Officer of Guardant Health, Inc. (GH), reported transactions involving the company's common stock.
• On September 1, 2025, Kalia acquired 711 shares of common stock through the vesting of Restricted Stock Units (RSUs) at a price of $0.
• Concurrently, Kalia disposed of 361 shares of common stock at a price of $67.42, typically to cover tax liabilities associated with the RSU vesting.
• Following these transactions, Kalia's direct beneficial ownership of common stock decreased from 19,211 shares to 18,850 shares.
• The RSU award was originally granted on November 2, 2021, with 25% vesting on September 1, 2022, and the remaining 75% vesting in equal quarterly installments over three years thereafter.

Sentiment

Score: 5

Explanation: The filing reports routine insider transactions related to equity compensation vesting and tax withholding, which are neutral events and do not indicate any significant positive or negative sentiment regarding the company's performance or outlook.

Positives

• The vesting of Restricted Stock Units (RSUs) indicates the continued retention and compensation of a key executive, Kumud Kalia, the Chief Information Officer.
• The acquisition of 711 shares at a $0 price reflects the realization of previously granted equity compensation, aligning executive interests with shareholder value.

Negatives

• The disposition of 361 shares, while likely for tax purposes, results in a slight reduction in the Chief Information Officer's direct beneficial ownership of common stock.

Future Outlook

The filing indicates that the remaining 75% of the RSU award will continue to vest in equal installments on each quarterly anniversary of September 1, 2022, over a three-year period, suggesting future routine vesting events.

Industry Context

NA

Stakeholder Impact

• Shareholders: Minimal impact as these are routine insider transactions related to executive compensation and do not reflect a change in company fundamentals or strategy.
• Employees: No direct impact on the broader employee base, but reinforces the company's equity compensation structure for executives.

Next Steps

• Future quarterly vesting of the remaining 75% of the RSU award will occur on each quarterly anniversary of September 1, 2022, over the next three years.

Key Dates

Recommendation

The filing details routine insider transactions (RSU vesting and tax-related share disposition) by a company executive. These transactions are expected and do not provide new information that would alter the fundamental investment thesis for Guardant Health. Therefore, a 'hold' recommendation is appropriate as there's no new catalyst for a change in investment stance based solely on this filing.

Keywords

Guardant Health, GH, Kumud Kalia, Chief Information Officer, Insider Transaction, Form 4, Restricted Stock Units, RSU vesting, Stock disposition, Equity compensation